You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

Article metrics

Article menu

Download PDFPDF

XML
Case report
Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: February 2021 to February 2023

AbstractFullPdf
Feb 2021300297156
Mar 202118918964
Apr 202111911957
May 202114714741
Jun 202115515537
Jul 202113213232
Aug 202112011947
Sep 2021999961
Oct 202111912039
Nov 202110110138
Dec 2021939320
Jan 2022646522
Feb 2022585827
Mar 202210110932
Apr 2022848617
May 2022838727
Jun 2022747723
Jul 2022687122
Aug 2022777732
Sep 2022696958
Oct 2022858840
Nov 2022565829
Dec 202239398
Jan 2023484816
Feb 2023646517
Total25442568962